000 01631 a2200457 4500
005 20250518061924.0
264 0 _c20200323
008 202003s 0 0 eng d
022 _a1879-0712
024 7 _a10.1016/j.ejphar.2019.172667
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYang, Yang
245 0 0 _aER-mediated anti-tumor effects of shikonin on breast cancer.
_h[electronic resource]
260 _bEuropean journal of pharmacology
_cNov 2019
300 _a172667 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aBreast Neoplasms
_xpathology
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aErbB Receptors
_xmetabolism
650 0 4 _aEstrogen Receptor alpha
_xmetabolism
650 0 4 _aEstrogen Receptor beta
_xmetabolism
650 0 4 _aG1 Phase Cell Cycle Checkpoints
_xdrug effects
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMCF-7 Cells
650 0 4 _aNaphthoquinones
_xpharmacology
650 0 4 _aReceptors, Estrogen
_xmetabolism
650 0 4 _aReceptors, G-Protein-Coupled
_xmetabolism
650 0 4 _aResting Phase, Cell Cycle
_xdrug effects
700 1 _aGao, Wenya
700 1 _aTao, Shiying
700 1 _aWang, Yanxia
700 1 _aNiu, Jianzhao
700 1 _aZhao, Piwen
700 1 _aRao, Chenchen
700 1 _aYang, Lei
773 0 _tEuropean journal of pharmacology
_gvol. 863
_gp. 172667
856 4 0 _uhttps://doi.org/10.1016/j.ejphar.2019.172667
_zAvailable from publisher's website
999 _c30136409
_d30136409